• Home

  • About Us

    • Overview

    • Culture

    • Team

  • Drug R & D

    • Fields

    • Indications

    • Pipeline

  • Technology Platform

    • Biotechnology Platform

    • Chemistry Service

  • News Center

    • Company News

    • Industry News

  • Join Us

    • Team Building

    • Career Development

  • Contact Us

CN
EN
About BroadenBio

About BroadenBio

——

Team

图片名称

Team

Core Team

Consultant

In October 2020, BrodenBio Co., Ltd. has completed the pre-A round of financing of tens of millions (CNY), led by Tao Capital, followed by Lapam Capital and Tibet Ruihai Enterprise Management Center (L.P.).

previous page

BroadenBio’s Pre-clinical Project on Class 1 New Drug Approved by Beijing Municipal Science and Technology Commission

BroadenBio Invested by KaiYuan HongDao Fund

next page

previous page

BroadenBio’s Pre-clinical Project on Class 1 New Drug Approved by Beijing Municipal Science and Technology Commission

next page

BroadenBio Invested by KaiYuan HongDao Fund

address:

A1-602, 88 Kechuang 6th Street, BDA, Beijing 100176

phone:

010-58222729

e-mail:

hr@broadenbio.com

 

Copyright ©2019 BroadenBio

SEO

Powered by www.300.cn

business license